These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 19776239

  • 1. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection.
    Moi ML, Lim CK, Takasaki T, Kurane I.
    J Gen Virol; 2010 Jan; 91(Pt 1):103-11. PubMed ID: 19776239
    [Abstract] [Full Text] [Related]

  • 2. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.
    Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I.
    J Virol Methods; 2010 Feb; 163(2):205-9. PubMed ID: 19781573
    [Abstract] [Full Text] [Related]

  • 3. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.
    Mady BJ, Erbe DV, Kurane I, Fanger MW, Ennis FA.
    J Immunol; 1991 Nov 01; 147(9):3139-44. PubMed ID: 1680925
    [Abstract] [Full Text] [Related]

  • 4. Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains.
    Puerta-Guardo H, Mosso C, Medina F, Liprandi F, Ludert JE, del Angel RM.
    J Gen Virol; 2010 Feb 01; 91(Pt 2):394-403. PubMed ID: 19828759
    [Abstract] [Full Text] [Related]

  • 5. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.
    Littaua R, Kurane I, Ennis FA.
    J Immunol; 1990 Apr 15; 144(8):3183-6. PubMed ID: 2139079
    [Abstract] [Full Text] [Related]

  • 6. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R, Hirai I, Sasaki T, Ono K, Ramasoota P, Ikuta K, Kurosu T.
    Antiviral Res; 2015 Dec 15; 124():61-8. PubMed ID: 26522769
    [Abstract] [Full Text] [Related]

  • 7. Influence of the human high-affinity IgG receptor FcgammaRI (CD64) on residual infectivity of neutralized dengue virus.
    Schlesinger JJ, Chapman SE.
    Virology; 1999 Jul 20; 260(1):84-8. PubMed ID: 10405359
    [Abstract] [Full Text] [Related]

  • 8. Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity.
    Paradkar PN, Ooi EE, Hanson BJ, Gubler DJ, Vasudevan SG.
    Biosci Rep; 2011 Jun 20; 31(3):221-30. PubMed ID: 20858223
    [Abstract] [Full Text] [Related]

  • 9. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
    Ito M, Mukai RZ, Takasaki T, Kotaki A, Kurane I.
    Arch Virol; 2010 Oct 20; 155(10):1617-24. PubMed ID: 20644969
    [Abstract] [Full Text] [Related]

  • 10. A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release.
    Brown MG, King CA, Sherren C, Marshall JS, Anderson R.
    J Leukoc Biol; 2006 Dec 20; 80(6):1242-50. PubMed ID: 16940332
    [Abstract] [Full Text] [Related]

  • 11. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B, Chanthavanich P, Gimenez S, Sirivichayakul C, Sabchareon A, Begue S, Yoksan S, Luxemburger C, Lang J.
    Vaccine; 2004 Sep 09; 22(27-28):3563-74. PubMed ID: 15315835
    [Abstract] [Full Text] [Related]

  • 12. A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells.
    Konishi E, Tabuchi Y, Yamanaka A.
    J Virol Methods; 2010 Feb 09; 163(2):360-7. PubMed ID: 19883692
    [Abstract] [Full Text] [Related]

  • 13. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.
    Guzman MG, Alvarez M, Halstead SB.
    Arch Virol; 2013 Jul 09; 158(7):1445-59. PubMed ID: 23471635
    [Abstract] [Full Text] [Related]

  • 14. Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection.
    Mady BJ, Kurane I, Erbe DV, Fanger MW, Ennis FA.
    J Gen Virol; 1993 May 09; 74 ( Pt 5)():839-44. PubMed ID: 8492089
    [Abstract] [Full Text] [Related]

  • 15. Dengue virus isolation relying on antibody-dependent enhancement mechanism using FcγR-expressing BHK cells and a monoclonal antibody with infection-enhancing capacity.
    Moi ML, Lim CK, Tajima S, Kotaki A, Saijo M, Takasaki T, Kurane I.
    J Clin Virol; 2011 Nov 09; 52(3):225-30. PubMed ID: 21824813
    [Abstract] [Full Text] [Related]

  • 16. Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells.
    Moi ML, Takasaki T, Saijo M, Kurane I.
    Arch Virol; 2014 Jan 09; 159(1):103-16. PubMed ID: 23900750
    [Abstract] [Full Text] [Related]

  • 17. Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection.
    Arévalo MT, Simpson-Haidaris PJ, Kou Z, Schlesinger JJ, Jin X.
    J Med Virol; 2009 Mar 09; 81(3):519-28. PubMed ID: 19152413
    [Abstract] [Full Text] [Related]

  • 18. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
    Moi ML, Takasaki T, Saijo M, Kurane I.
    Trans R Soc Trop Med Hyg; 2013 Jan 09; 107(1):51-8. PubMed ID: 23296697
    [Abstract] [Full Text] [Related]

  • 19. [Pathophysiological mechanisms of dengue fever: critical review of current concepts].
    Deparis X, Maréchal V, Matheus S.
    Med Trop (Mars); 2009 Aug 09; 69(4):351-7. PubMed ID: 19725385
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
    Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ.
    Proc Natl Acad Sci U S A; 2007 May 29; 104(22):9422-7. PubMed ID: 17517625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.